Related Experiment Videos
DNA-microarray analysis of brain cancer: molecular classification for therapy
Paul S Mischel1, Timothy F Cloughesy, Stanley F Nelson
1Department of Pathology and Laboratory Medicine, the Henry E. Singleton Brain Cancer Research Program at the David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA. pmischel@mednet.ucla.edu
Nature Reviews. Neuroscience
|September 21, 2004
Summary
DNA microarrays help identify distinct brain cancer patient groups, improving treatment selection for better outcomes. This technology analyzes thousands of genes to personalize brain tumor therapy.
Area of Science:
- Neuro-oncology
- Genomics
- Molecular Biology
Background:
- Primary brain tumors are highly lethal due to resistance to current treatments.
- Personalizing therapy is crucial for improving patient survival in brain cancer.
- Identifying specific patient subsets is key to effective treatment strategies.
Purpose of the Study:
- To review the application of DNA microarrays in optimizing brain cancer therapy.
- To highlight the potential of gene expression profiling for personalized brain tumor treatment.
Main Methods:
- Utilizing DNA-microarray-based technologies for high-throughput gene expression analysis.
- Analyzing gene expression patterns to identify novel patient subgroups.
- Correlating gene expression profiles with patient survival data.
Main Results:
- DNA microarrays have revealed previously unrecognized patient subsets with distinct survival rates.
- Gene expression analysis facilitates a deeper understanding of brain tumor heterogeneity.
- Progress has been made in applying these technologies to tailor brain cancer treatments.
Conclusions:
- DNA microarrays are a powerful tool for stratifying brain cancer patients.
- This technology holds significant promise for optimizing therapeutic strategies in neuro-oncology.
- Personalized medicine approaches using gene expression data are advancing brain cancer care.